Abstract: The disclosure relates to bacterial compositions, prebiotics and methods of use thereof. The bacterial compositions may include bacteria of the genera Rothia, Gemella or Roseomonas, and combinations thereof. The bacterial compositions and prebiotics may be used in treating inflammation, such as inflammation of the respiratory tract and skin inflammation.

Abstract: A method for altering and/or disrupting a microbiological film is described. The method comprises introducing a composition into a microbiological film, the composition comprising nano- or microparticles having an electron density that can couple with a photon wave of electromagnetic radiation. The method also comprises irradiating said microbiological film by said electromagnetic radiation such as to form a vapour bubbles using said nano- or microparticles in said microbiological biofilm, thereby generating a mechanical force for locally altering and/or disrupting said microbiological film when said vapour bubbles expand and/or collapse.

Abstract: The present invention relates to hamamelitannin analogues, pharmaceutical compositions comprising the same, and combinations thereof with anti-microbial agents such as antibiotics or disinfectants. It in particular relates to the use of the compounds, compositions and combinations according to this invention in human or veterinary medicine, more in particular for use in the prevention and/or treatment of bacterial infections, such as Staphylococcus aureus infections, in humans or animals.

Abstract: The present invention relates to hamamelitannin analogues, pharmaceutical compositions comprising the same, and combinations thereof with anti-microbial agents such as antibiotics or disinfectants. It in particular relates to the use of the compounds, compositions and combinations according to this invention in human or veterinary medicine, more in particular for use in the prevention and/or treatment of bacterial infections, such as Staphylococcus aureus infections, in humans or animals.